2019. FRAGMENT-BASED DRUG DESIGN TO INHIBIT DNA METHYLTRANSFERASE 1 (DNMT1) FOR BREAST CANCER THERAPY. GEOMATE Journal. 17, 62 (Oct. 2019), 35–40.